col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


51 Results       Page 1

 [1] 
Wiley: eJHaem
  original article Date Title Authors   All Authors
1 [GO] 2022―Jun―16 Adult paroxysmal cold hemoglobinuria following mRNA COVID-19 vaccination Kyohei Misawa, Hajime Yasuda, Daisuke Koyama, Tadaaki Inano, Akemi Inoguchi, Chinami Shirasu, et al. (+4)
2 [GO] 2022―Jun―14 COVID-19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta-analysis Yeong Jer Lim, Umair Khan, Indrani Karpha, Andrew Ross, Muhammad Saif, Mats Remberger, et al. (+3)
3 [GO] 2022―Jun―08 Into the limelight: TPA for critically ill Covid-19 patients Eslam Abbas, Ahmed Mahdy, Rawad Tarek, Nawar Jabbour, Huda Al-Foudri
4 [GO] 2022―May―31 LGL leukemia patients exhibit substantial protective humoral responses following SARS-CoV-2 vaccination Heejin Cheon, Omar Elghawy, Bryna C. Shemo, David J. Feith, Thomas P. Loughran
5 [GO] 2022―May―23 tPA or not tPA? Lysis therapy in the setting of COVID-19 and ECMO Anjelica Cromartie, Meghan Prin
6 [GO] 2022―May―12 COVID-19-associated secondary hemophagocytic lymphohistiocytosis requiring hematopoietic cell transplant Jacob R. Greenmyer, Kirk D Wyatt, Sam Milanovich, Mira A. Kohorst, Asmaa Ferdjallah
7 [GO] 2022―May―05 Sickle cell disease patients with COVID-19 in Guadeloupe: Surprisingly favorable outcomes Emmanuelle Bernit, Marc Romana, Scylia Alexis-Fardini, Vanessa Tarer, Pierre-Marie Roger, Lydia Doumdo, et al. (+5)
8 [GO] 2022―May―05 Severe aplastic anaemia after serial vaccinations for SARS-CoV-2, pneumococcus and seasonal influenza Xiao Wang, Dorottya Laczko, Gabriel C. Caponetti, Susan Rabatin, Daria V. Babushok
9 [GO] 2022―Mar―22 Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial model Conor McCafferty, Leo Lee, Tengyi Cai, Slavica Praporski, Julian Stolper, Vasiliki Karlaftis, et al. (+16)
10 [GO] 2022―Mar―10 Immune thrombocytopenia management during COVID-19 pandemic: An Italian monocentric experience Gianfranco Lapietra, Antonietta Ferretti, Erminia Baldacci, Antonio Chistolini, Cristina Santoro
11 [GO] 2022―Feb―24 REGEN-COV antibody combination in patients with lymphoproliferative malignancies and SARS-CoV-2 infection Yotam Bronstein, Irit Avivi, Yael C Cohen, Eugene Feigin, Chava Perry, Yair Herishanu
12 [GO] 2022―Feb―08 Acute chest syndrome and COVID-19 in hydroxyurea naïve sickle cell disease patient in a low resource setting William Frank Mawalla, Ahlam Nasser, James Salumu Jingu, Happiness Joseph, Lilian Gasper Mmbaga, Eunice Shija, et al. (+4)
13 [GO] 2021―Dec―04 Respiratory syncytial virus pneumonia in an adult cord blood transplant recipient during the SARS-CoV-2 outbreak Takaaki Konuma, Masamichi Isobe, Seiko Kato, Satoshi Takahashi, Yasuhito Nannya
14 [GO] 2021―Nov―26 Erytra blood group analyser and kode technology testing of SARS-CoV-2 antibodies among convalescent patients and vaccinated individuals Christof Weinstock, Willy A. Flegel, Kshitij Srivastava, Sabine Kaiser, Hubert Schrezenmeier, Chrysanthi Tsamadou, et al. (+4)
15 [GO] 2021―Nov―25 Children with sickle cell disease and severe COVID-19 presenting single nucleotide polymorphisms in innate immune response genes - A case report Natália Lima Pessoa, Lilian Martins Oliveira Diniz, Adriana de Souza Andrade, Erna Geessien Kroon, Aline Almeida Bentes, Marco Antônio Campos
16 [GO] 2021―Nov―20 Lymphoid blast crisis after prolonged treatment-free remission in chronic myeloid leukaemia after tyrosine kinase inhibitor de-escalation during the COVID-19 pandemic Daniele Avenoso, Dragana Milojkovic, James Clark, Christopher Pocock, Victoria Potter, Deborah Yallop, Guy Hannah
17 [GO] 2021―Nov―16 Acquired thrombotic thrombocytopenic purpura following Pfizer COVID-19 vaccination Mawaddah Alislambouli, Andy Veras Victoria, Jyoti Matta, Faye Yin
18 [GO] 2021―Oct―15 Using lysis therapy to treat five critically ill COVID-19 patients who show echocardiographic criteria of right ventricular strain Ahmed Mahdy, Eslam Abbas, Rawad Tarek, Nawar Jabbour, Huda Al-Foudri
19 [GO] 2021―Oct―14 Axillary lymph nodes on PET in Hodgkin lymphoma after COVID-19 vaccination Anne I. J. Arens, Konnie M. Hebeda, Martin Hutchings, Wouter J. Plattel, Wendy B. C. Stevens
20 [GO] 2021―Oct―02 Incidence of symptomatic image-confirmed venous thromboembolism in outpatients managed in a hospital-led COVID-19 virtual ward Susan Shapiro, Karim Fouad Alber, Joshua Morton, George Wallis, Meriel Britton, Alex Bunn, et al. (+10)
21 [GO] 2021―Aug―27 The negative impact of the COVID-19 pandemic on UK haematology registrars’ well-being and training: Results of a UK nationwide survey Mohammed OA Altohami, Alexander Langridge, Enas MK Shareef, Phillip LR Nicolson
22 [GO] 2021―Aug―14 Lymphadenopathy with florid lymphoid and Langerhans cell hyperplasia and hemophagocytosis mimicking lymphoma after COVID-19 mRNA vaccination Suzanne Tintle, Mingyi Chen
23 [GO] 2021―Aug―12 CANOMAD unmasked by COVID-19 in a man with Waldenström's macroglobulinaemia Hamish D. Morrison, Jonathan Cleaver, Natasha Lander, Philippa Lowden, Kate Hale, Kanchan Sharma, James Stevens
24 [GO] 2021―Jul―23 Hypermetabolic lymphadenopathy on positron emission tomography scan following COVID-19 vaccination: A mimicker of disease progression in Hodgkin lymphoma Adam Suleman, Alexander Bilbily, Matthew Cheung, Lisa Chodirker
25 [GO] 2021―Jul―19 No evidence of SARS-CoV-2 transmission through transfusion of human blood products: A systematic review William Frank Mawalla, Belinda J. Njiro, George M. Bwire, Ahlam Nasser, Bruno Sunguya
26 [GO] 2021―Jun―22 Endothelial dysfunction and its critical role in COVID-19-associated coagulopathy: Defibrotide as an endothelium-protective, targeted therapy David García-Bernal, Edward Richardson, Israel Vlodavsky, Carmelo Carlo-Stella, Massimo Iacobelli, Rubén Jara, et al. (+2)
27 [GO] 2021―Jun―19 B-cell haematological malignancies and SARS-CoV-2 infection: Could immunological interventions influence the outcome? Juliana Ochoa-Grullón, Ascensión Peña Cortijo, Kissy Guevara-Hoyer, Carlos Jiménez García, Eduardo Fuente, Antonia Rodríguez Peña, et al. (+3)
28 [GO] 2021―Jun―18 Low SARS-CoV-2 seroprevalence in a cohort of Brazilian sickle cell disease patients: Possible effects of emphasis on social isolation for a population initially considered to be at very high risk Luiza Francisco Trafane, Vitor Antonio da Costa, Adriana da Silva Santos Duarte, Audrey Basso Zangirolami, José Luiz Proenca-Modena, Paula Melo Campos, et al. (+4)
29 [GO] 2021―Jun―07 COVID-19-associated pseudothrombocytopenia Ruben Van Dijck, Mandy N. Lauw, Maurice Swinkels, Henk Russcher, A.J. Gerard Jansen
30 [GO] 2021―Jun―02 Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients Patrice Chevallier, Marianne Coste-Burel, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marie C. Béné, et al. (+13)
31 [GO] 2021―May―19 Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine Mona Al-Ahmad, Mona Al-Rasheed, Neveen Abo Bakr Shalaby
32 [GO] 2021―May―18 Lessons learnt from COVID-19 coagulopathy Jecko Thachil
33 [GO] 2021―May―14 Models of care for chronic myeloid leukemia patients during the COVID-19 pandemic in the United Kingdom: Changes in patient attitudes to remote consultations and future implications Nicholas Duncan, Nigel Deekes, David FitzGerald, Tin Wai Terry Ng, Manoj Raghavan
34 [GO] 2021―May―07 Mild anemia as a single independent predictor of mortality in patients with COVID-19 Douglas Tremblay, Joseph L. Rapp, Naomi Alpert, Wil Lieberman-Cribbin, John Mascarenhas, Emanuela Taioli, Saghi Ghaffari
35 [GO] 2021―May―06 In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective study Mohammed Al-Jarallah, Rajesh Rajan, Ahmad Al Saber, Jiazhu Pan, Ahmad T. Al-Sultan, Hassan Abdelnaby, et al. (+13)
36 [GO] 2021―May―04 Green bodies: Inclusions in a critically ill COVID-19 patient Ioulia Chaliori, Nikolaos J. Tsagarakis, Sofia Chaniotaki, Georgios Androutsos, Dimitrios Liakopoulos, Elpiniki Kritikou-Griva
37 [GO] 2021―May―04 Persistent immune thrombocytopaenic purpura associated with SARS-CoV-2 infection Yoshiki Furukawa, Miki Ando, Yoko Azusawa, Shintaro Kinoshita, Sakiko Harada, Tomonori Ochiai, et al. (+5)
38 [GO] 2021―Apr―02 Blood group type A secretors are associated with a higher risk of COVID-19 cardiovascular disease complications Tosti J. Mankelow, Belinda K. Singleton, Pedro L. Moura, Christian J. Stevens-Hernandez, Nicola M. Cogan, Gyongyver Gyorffy, et al. (+16)
39 [GO] 2021―Feb―11 Is sickle cell disease a risk factor for severe COVID-19 outcomes in hospitalized patients? A multicenter national retrospective cohort study Abdulkarim Abdulrahman, Mohammed Wael, Fajer AlAmmadi, Zahra Almosawi, Reem Alsherooqi, Manal Abduljalil, et al. (+2)
40 [GO] 2021―Jan―26 Things are not always what they seem: Histopathology of Covid-19 lymphadenopathy Catherine M. Tucker, Guldeep K. Uppal
41 [GO] 2021―Jan―15 Presentation, management, and outcomes of COVID-19 in patients with sickle cell disease Nwabundo Anusim, Ruby Gupta, Hyceinth Ahaneku, Candace Franklin, Savitha Balaraman, Marianne Huben, Ishmael Jaiyesimi
42 [GO] 2020―Dec―08 First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID-19 in an allogeneic stem cell transplant patient Nicholas Fordham, Emma Baker, Daniel Forton, Matthias Klammer, Kamal Patel, Dara Qadir, et al. (+3)
43 [GO] 2020―Dec―01 Plasma exchange for COVID-19 thrombo-inflammatory disease Nishkantha Arulkumaran, Mari Thomas, David Brealey, Ferras Alwan, Deepak Singh, Michael Lunn, et al. (+8)
44 [GO] 2020―Nov―06 Hematidrosis as a manifestation of COVID-19 containment-induced stress Christian Récher
45 [GO] 2020―Oct―31 Does COVID-19 really impact on the oxy-hemoglobin dissociation curve? Flávia Nóbrega, Vitor Augusto Queiroz Mauad, Davimar Miranda Maciel Borducchi
46 [GO] 2020―Oct―08 COVID-19 and the pulmonary complications of sickle cell disease Thivya Sivalingam, Baba Inusa, Pat Doyle, Eugene Oteng-Ntim
47 [GO] 2020―Sep―20 Ibrutinib for chronic lymphocytic leukemia in the setting of respiratory failure from severe COVID-19 infection: Case report and literature review Adam Yuh Lin, Michael J. Cuttica, Michael G. Ison, Leo I. Gordon
48 [GO] 2020―Aug―30 Low morbidity and mortality with COVID-19 in sickle cell disease: A single center experience Preethi Ramachandran, Abhilash Perisetti, Balachandar Kathirvelu, Mahesh Gajendran, Snigdha Ghanta, Ifeanyichkwu Onukogu, et al. (+2)
49 [GO] 2020―Aug―04 Sickle cell disease and COVID-19: Atypical presentations and favorable outcomes Marie-Agnès Azerad, Firas Bayoudh, Thierry Weber, Jean-Marc Minon, Olivier Ketelslegers, Marie Hoyoux, et al. (+14)
50 [GO] 2020―Jul―04 Clinical management of a Nigerian patient affected by sickle cell disease with rare blood group and persistent SARS-CoV-2 positivity Micol Quaresima, Virginia Quaresima, Matteo Maria Naldini, Daniela Maria Cirillo, Angela Ferrari, Angela Mazzi, et al. (+3)
51 [GO] 2020―Jun―30 Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cells Florian Lüke, Evelyn Orsó, Jana Kirsten, Hendrik Poeck, Matthias Grube, Daniel Wolff, et al. (+13)
 [1] 

51 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec